Both in Biotechnology
ProKidney vs Cabaletta Bio
Over the past year PROK returned −61.6% and CABA returned −52.3%; their daily moves had a correlation of 0.35.
PROK −61.6% CABA −52.3%Growth of $1, one year, split-adjusted
| Metric | PROK | CABA |
|---|---|---|
| Price | $1.10 | $1.44 |
| Market cap | $228.8M | $243.3M |
| Today | +2.34% | +1.06% |
| 1 month | −31.6% | −29.0% |
| 6 months | −44.1% | −61.5% |
| Year to date | −51.1% | −34.5% |
| 1 year | −61.6% | −52.3% |
| Revenue growth (YoY) | −32.1% | — |
| Gross margin | 100.0% | — |
| Net margin | −18948.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 279.7× | — |
| Net cash | $181.6M | $205.1M |
| Dividend yield | — | — |
| Volatility (60d) | 85.1% | 78.8% |
| Short % of float | 27.4% | 27.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).